The global pharmaceutical rapid microbiology testing market size is calculated at USD 1.32 billion in 2025 and is forecasted to reach around USD 5.64 billion by 2034, accelerating at a CAGR of 17.54% from 2025 to 2034. The North America market size surpassed USD 425.60 million in 2024 and is expanding at a CAGR of 17.70% during the forecast period. The market sizing and forecasts are revenue-based (USD Million/Billion), with 2024 as the base year.
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
3.1. Market Snapshot
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Analysis
4.3.3. Downstream Buyer Analysis
5.1. COVID-19 Landscape: Pharmaceutical Rapid Microbiology Testing Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
8.1. Pharmaceutical Rapid Microbiology Testing Market Revenue and Volume, by Technology Type
8.1.1. Polymerase Chain Reaction (PCR)
8.1.1.1. Market Revenue and Volume Forecast
8.1.2. ATP Bioluminescence
8.1.2.1. Market Revenue and Volume Forecast
8.1.3. Flow Cytometry
8.1.3.1. Market Revenue and Volume Forecast
8.1.4. Enzyme-Linked Immunosorbent Assay (ELISA)
8.1.4.1. Market Revenue and Volume Forecast
8.1.5. Chromatography
8.1.5.1. Market Revenue and Volume Forecast
8.1.6. Biosensors & Bioassays
8.1.6.1. Market Revenue and Volume Forecast
8.1.7. Impedance Microbiology
8.1.7.1. Market Revenue and Volume Forecast
8.1.8. Others (e.g., Microfluidics, Microarray)
8.1.8.1. Market Revenue and Volume Forecast
9.1. Pharmaceutical Rapid Microbiology Testing Market Revenue and Volume, by Product Type
9.1.1. Instruments
9.1.1.1. Market Revenue and Volume Forecast
9.1.2. Reagents & Consumables
9.1.2.1. Market Revenue and Volume Forecast
9.1.3 Software & Services
9.1.3.1. Market Revenue and Volume Forecast
10.1. Pharmaceutical Rapid Microbiology Testing Market Revenue and Volume, by Application
10.1.1. Biopharmaceuticals
10.1.1.1. Market Revenue and Volume Forecast
10.1.2 Small Molecule Pharmaceuticals
10.1.2.1. Market Revenue and Volume Forecast
10.1.3. Vaccines
10.1.3.1. Market Revenue and Volume Forecast
10.1.4. Contract Research Organizations (CROs)
10.1.4.1. Market Revenue and Volume Forecast
10.1.5. Academic & Research Institutes
10.1.5.1. Market Revenue and Volume Forecast
11.1. Pharmaceutical Rapid Microbiology Testing Market Revenue and Volume, by Microorganism Type Tested
11.1.1. Bacteria
11.1.1.1. Market Revenue and Volume Forecast
11.1.2. Fungi (Yeast and Mold)
11.1.2.1. Market Revenue and Volume Forecast
11.1.3. Viruses
11.1.3.1. Market Revenue and Volume Forecast
11.1.4. Mycoplasma
11.1.4.1. Market Revenue and Volume Forecast
11.1.5. Endotoxins
11.1.5.1. Market Revenue and Volume Forecast
12.1. Pharmaceutical Rapid Microbiology Testing Market Revenue and Volume, by End User
12.1.1. Pharmaceutical & Biotechnology Companies
12.1.1.1. Market Revenue and Volume Forecast
12.1.2. Contract Manufacturing Organizations (CMOs)
12.1.2.1. Market Revenue and Volume Forecast
12.1.3. Hospitals & Diagnostic Laboratories
12.1.3.1. Market Revenue and Volume Forecast
12.1.4. Research & Academic Institutes
12.1.4.1. Market Revenue and Volume Forecast
13.1. Pharmaceutical Rapid Microbiology Testing Market Revenue and Volume, by Testing Type
13.1.1. Sterility Testing
13.1.1.1. Market Revenue and Volume Forecast
13.1.2. Environmental Monitoring
13.1.2.1. Market Revenue and Volume Forecast
13.1.3. Bioburden Testing
13.1.3.1. Market Revenue and Volume Forecast
13.1.4. Raw Material Testing
13.1.4.1. Market Revenue and Volume Forecast
13.1.5. Water Testing
13.1.5.1. Market Revenue and Volume Forecast
14.1. North America
14.1.1. Market Revenue and Volume Forecast, by Technology Type
14.1.2. Market Revenue and Volume Forecast, by Product Type
14.1.3. Market Revenue and Volume Forecast, by Application
14.1.4. Market Revenue and Volume Forecast, by Microorganism Type Tested
14.1.5. Market Revenue and Volume Forecast, by End User
14.1.6. Market Revenue and Volume Forecast, by Testing Type
14.1.7. U.S.
14.1.7.1. Market Revenue and Volume Forecast, by Technology Type
14.1.7.2. Market Revenue and Volume Forecast, by Product Type
14.1.7.3. Market Revenue and Volume Forecast, by Application
14.1.7.4. Market Revenue and Volume Forecast, by Microorganism Type Tested
14.1.8. Market Revenue and Volume Forecast, by End User
14.1.8.1. Market Revenue and Volume Forecast, by Testing Type
14.1.9. Rest of North America
14.1.9.1. Market Revenue and Volume Forecast, by Technology Type
14.1.9.2. Market Revenue and Volume Forecast, by Product Type
14.1.9.3. Market Revenue and Volume Forecast, by Application
14.1.9.4. Market Revenue and Volume Forecast, by Microorganism Type Tested
14.1.10. Market Revenue and Volume Forecast, by End User
14.1.11. Market Revenue and Volume Forecast, by Testing Type
14.2. Europe
14.2.1. Market Revenue and Volume Forecast, by Technology Type
14.2.2. Market Revenue and Volume Forecast, by Product Type
14.2.3. Market Revenue and Volume Forecast, by Application
14.2.4. Market Revenue and Volume Forecast, by Microorganism Type Tested
14.2.5. Market Revenue and Volume Forecast, by End User
14.2.6. Market Revenue and Volume Forecast, by Testing Type
14.2.8. UK
14.2.8.1. Market Revenue and Volume Forecast, by Technology Type
14.2.8.2. Market Revenue and Volume Forecast, by Product Type
14.2.8.3. Market Revenue and Volume Forecast, by Application
14.2.9. Market Revenue and Volume Forecast, by Microorganism Type Tested
14.2.10. Market Revenue and Volume Forecast, by End User
14.2.10.1. Market Revenue and Volume Forecast, by Testing Type
14.2.11. Germany
14.2.11.1. Market Revenue and Volume Forecast, by Technology Type
14.2.11.2. Market Revenue and Volume Forecast, by Product Type
14.2.11.3. Market Revenue and Volume Forecast, by Application
14.2.12. Market Revenue and Volume Forecast, by Microorganism Type Tested
14.2.13. Market Revenue and Volume Forecast, by End User
14.2.14. Market Revenue and Volume Forecast, by Testing Type
14.2.15. France
14.2.15.1. Market Revenue and Volume Forecast, by Technology Type
14.2.15.2. Market Revenue and Volume Forecast, by Product Type
14.2.15.3. Market Revenue and Volume Forecast, by Application
14.2.15.4. Market Revenue and Volume Forecast, by Microorganism Type Tested
14.2.16. Market Revenue and Volume Forecast, by End User
14.2.16.1. Market Revenue and Volume Forecast, by Testing Type
14.2.17. Rest of Europe
14.2.17.1. Market Revenue and Volume Forecast, by Technology Type
14.2.17.2. Market Revenue and Volume Forecast, by Product Type
14.2.17.3. Market Revenue and Volume Forecast, by Application
14.2.17.4. Market Revenue and Volume Forecast, by Microorganism Type Tested
14.2.18. Market Revenue and Volume Forecast, by End User
14.2.18.1. Market Revenue and Volume Forecast, by Testing Type
14.3. APAC
14.3.1. Market Revenue and Volume Forecast, by Technology Type
14.3.2. Market Revenue and Volume Forecast, by Product Type
14.3.3. Market Revenue and Volume Forecast, by Application
14.3.4. Market Revenue and Volume Forecast, by Microorganism Type Tested
14.3.5. Market Revenue and Volume Forecast, by End User
14.3.6. Market Revenue and Volume Forecast, by Testing Type
14.3.7. India
14.3.7.1. Market Revenue and Volume Forecast, by Technology Type
14.3.7.2. Market Revenue and Volume Forecast, by Product Type
14.3.7.3. Market Revenue and Volume Forecast, by Application
14.3.7.4. Market Revenue and Volume Forecast, by Microorganism Type Tested
14.3.8. Market Revenue and Volume Forecast, by End User
14.3.9. Market Revenue and Volume Forecast, by Testing Type
14.3.10. China
14.3.10.1. Market Revenue and Volume Forecast, by Technology Type
14.3.10.2. Market Revenue and Volume Forecast, by Product Type
14.3.10.3. Market Revenue and Volume Forecast, by Application
14.3.10.4. Market Revenue and Volume Forecast, by Microorganism Type Tested
14.3.11. Market Revenue and Volume Forecast, by End User
14.3.11.1. Market Revenue and Volume Forecast, by Testing Type
14.3.12. Japan
14.3.12.1. Market Revenue and Volume Forecast, by Technology Type
14.3.12.2. Market Revenue and Volume Forecast, by Product Type
14.3.12.3. Market Revenue and Volume Forecast, by Application
14.3.12.4. Market Revenue and Volume Forecast, by Microorganism Type Tested
14.3.12.5. Market Revenue and Volume Forecast, by End User
14.3.12.6. Market Revenue and Volume Forecast, by Testing Type
14.3.13. Rest of APAC
14.3.13.1. Market Revenue and Volume Forecast, by Technology Type
14.3.13.2. Market Revenue and Volume Forecast, by Product Type
14.3.13.3. Market Revenue and Volume Forecast, by Application
14.3.13.4. Market Revenue and Volume Forecast, by Microorganism Type Tested
14.3.13.5. Market Revenue and Volume Forecast, by End User
14.3.13.6. Market Revenue and Volume Forecast, by Testing Type
14.4. MEA
14.4.1. Market Revenue and Volume Forecast, by Technology Type
14.4.2. Market Revenue and Volume Forecast, by Product Type
14.4.3. Market Revenue and Volume Forecast, by Application
14.4.4. Market Revenue and Volume Forecast, by Microorganism Type Tested
14.4.5. Market Revenue and Volume Forecast, by End User
14.4.6. Market Revenue and Volume Forecast, by Testing Type
14.4.7. GCC
14.4.7.1. Market Revenue and Volume Forecast, by Technology Type
14.4.7.2. Market Revenue and Volume Forecast, by Product Type
14.4.7.3. Market Revenue and Volume Forecast, by Application
14.4.7.4. Market Revenue and Volume Forecast, by Microorganism Type Tested
14.4.8. Market Revenue and Volume Forecast, by End User
14.4.9. Market Revenue and Volume Forecast, by Testing Type
14.4.10. North Africa
14.4.10.1. Market Revenue and Volume Forecast, by Technology Type
14.4.10.2. Market Revenue and Volume Forecast, by Product Type
14.4.10.3. Market Revenue and Volume Forecast, by Application
14.4.10.4. Market Revenue and Volume Forecast, by Microorganism Type Tested
14.4.11. Market Revenue and Volume Forecast, by End User
14.4.12. Market Revenue and Volume Forecast, by Testing Type
14.4.13. South Africa
14.4.13.1. Market Revenue and Volume Forecast, by Technology Type
14.4.13.2. Market Revenue and Volume Forecast, by Product Type
14.4.13.3. Market Revenue and Volume Forecast, by Application
14.4.13.4. Market Revenue and Volume Forecast, by Microorganism Type Tested
14.4.13.5. Market Revenue and Volume Forecast, by End User
14.4.13.6. Market Revenue and Volume Forecast, by Testing Type
14.4.14. Rest of MEA
14.4.14.1. Market Revenue and Volume Forecast, by Technology Type
14.4.14.2. Market Revenue and Volume Forecast, by Product Type
14.4.14.3. Market Revenue and Volume Forecast, by Application
14.4.14.4. Market Revenue and Volume Forecast, by Microorganism Type Tested
14.4.14.5. Market Revenue and Volume Forecast, by End User
14.4.14.6. Market Revenue and Volume Forecast, by Testing Type
14.5. Latin America
14.5.1. Market Revenue and Volume Forecast, by Technology Type
14.5.2. Market Revenue and Volume Forecast, by Product Type
14.5.3. Market Revenue and Volume Forecast, by Application
14.5.4. Market Revenue and Volume Forecast, by Microorganism Type Tested
14.5.5. Market Revenue and Volume Forecast, by End User
14.5.6. Market Revenue and Volume Forecast, by Testing Type
14.5.7. Brazil
14.5.7.1. Market Revenue and Volume Forecast, by Technology Type
14.5.7.2. Market Revenue and Volume Forecast, by Product Type
14.5.7.3. Market Revenue and Volume Forecast, by Application
14.5.7.4. Market Revenue and Volume Forecast, by Microorganism Type Tested
14.5.8. Market Revenue and Volume Forecast, by End User
14.5.8.1. Market Revenue and Volume Forecast, by Testing Type
14.5.9. Rest of LATAM
14.5.9.1. Market Revenue and Volume Forecast, by Technology Type
14.5.9.2. Market Revenue and Volume Forecast, by Product Type
14.5.9.3. Market Revenue and Volume Forecast, by Application
14.5.9.4. Market Revenue and Volume Forecast, by Microorganism Type Tested
14.5.9.5. Market Revenue and Volume Forecast, by End User
14.5.9.6. Market Revenue and Volume Forecast, by Testing Type
15.1. Merck KGaA (MilliporeSigma)
15.1.1. Company Overview
15.1.2. Product Offerings
15.1.3. Financial Performance
15.1.4. Recent Initiatives
15.2. Charles River Laboratories International, Inc.
15.2.1. Company Overview
15.2.2. Product Offerings
15.2.3. Financial Performance
15.2.4. Recent Initiatives
15.3. Pall Life Sciences
15.3.1. Company Overview
15.3.2. Product Offerings
15.3.3. Financial Performance
15.3.4. Recent Initiatives
15.4. Eurofins Scientific
15.4.1. Company Overview
15.4.2. Product Offerings
15.4.3. Financial Performance
15.4.4. Recent Initiatives
15.5. Qiagen N.V.
15.5.1. Company Overview
15.5.2. Product Offerings
15.5.3. Financial Performance
15.5.4. Recent Initiatives
15.6. BioMérieux SA
15.6.1. Company Overview
15.6.2. Product Offerings
15.6.3. Financial Performance
15.6.4. Recent Initiatives
15.7. Neogen Corporation
15.7.1. Company Overview
15.7.2. Product Offerings
15.7.3. Financial Performance
15.7.4. Recent Initiatives
15.8. Nova Biomedical Corporation
15.8.1. Company Overview
15.8.2. Product Offerings
15.8.3. Financial Performance
15.8.4. Recent Initiatives
15.9. LuminUltra Technologies Ltd.
15.9.1. Company Overview
15.9.2. Product Offerings
15.9.3. Financial Performance
15.9.4. Recent Initiatives
15.10. Accelerate Diagnostics, Inc.
15.10.1. Company Overview
15.10.2. Product Offerings
15.10.3. Financial Performance
15.10.4. Recent Initiatives
16.1. Primary Research
16.2. Secondary Research
16.3. Assumptions
17.1. About Us
17.2. Glossary of Terms
For questions or customization requests, please reach out to us at sales@precedenceresearch.com
Plan your call and get expert insights!
Schedule a Meeting
No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client
Get a Sample
Report Description
Get a Sample
Report Description